Differentiated nuclei can experimentally be returned to an undifferentiated embryonic state after nuclear transfer (NT) to unfertilized metaphase II (MII) oocytes. Nuclear reprogramming is triggered immediately after somatic cell nucleus transfer (SCNT) into recipient cytoplasm and this period is regarded as a key stage for optimizing reprogramming. In a recent study (Miyamoto et al. 2010 JBC), use of m-carboxycinnamic acid bishydroxamide (CBHA), a histone deacetylase inhibitor, during the in vitro early culture of murine cloned embryos modifies the acetylation status of somatic nuclei and increases the developmental competence of SCNT embryos. Thus, we examined the effects of CBHA on the in vitro developmental competence and pluripotent gene expression of porcine SCNT embryos. The porcine cloned embryos were treated with a 100 μM concentration of CBHA during the in vitro early culture (10 h) and then were assessed to cleavage rates and development to the blastocyst stage. In addition, pluripotent gene expression of SCNT embryos was analysed by RT-PCR. All data were analysed by chi-square. Following 4 replicates (207 and 124 for NT and CBHA-treated NT embryos, respectively), no significant difference was observed between NT and CBHA-treated NT embryos for cleavage rate (83.9 vs 82.2%). However, the developmental competence to the blastocyst stage differed significantly between NT and CBHA-treated NT embryos (6.8 vs 18.6%; P < 0.05). In addition, pluripotent transcription factors including Oct4, Nanog and Sox2 were higher expressed in the cloned embryos treated with CBHA (P < 0.05). The results of the present study suggest that treatment with CBHA as a histone deacetylase inhibitor significantly increased the developmental competence as well as the pluripotent gene expression of porcine SCNT embryos.
This work was partly supported by a grant from the NRF (2011-0013703) and the Next-Generation BioGreen 21 Program (No. PJ008209), Rural Development Administration, Republic of Korea.
The ups and downs of somatic cell nucleus transfer (SCNT) in humans
